Year archive

Quantumzyme Corp. — 2026 filings

All 8 regulatory filings released by Quantumzyme Corp. (QTZM) in 2026, sourced directly from the official regulator.

8 Filings

2026 Period

2026 filings (8)

Filing	Released	Lang
Quantum Genesis AI Corp. Issues Statement Regarding OTC Markets Caveat Emptor Designation Regulatory Filings	2026-03-12	English
Quantumzyme Research Published in the Journal of Molecular Graphics & Modelling Study Highlights In Silico Enzyme Engineering Approach for Sustainable Drug Manufacturing Regulatory Filings	2026-02-12	English
Quantumzyme Announces Strategic Capital Structure Initiative, Corporate Rebranding Update, and Planned 4-for-1 Forward Stock Split Share Issue/Capital Change	2026-02-09	English
Quantumzyme Featured on Cover of RSC Sustainability for Research in Enzyme Engineering for Ibuprofen Synthesis Regulatory Filings	2026-01-30	English
Quantumzyme to Attend 2026 BIO International Convention Regulatory Filings	2026-01-28	English
Quantumzyme Announces Next-Generation Enzyme Engineering Platform for More Efficient Pharmaceutical Manufacturing Regulatory Filings	2026-01-27	English
Quantumzyme Corp. Provides 2025 Corporate Update and Outlines Strategic Priorities for 2026 Regulatory Filings	2026-01-26	English
Quantumzyme Corp. Announces Memorandum of Understanding With Predictive Research Inc. to Explore AI-Enabled Applications in Green Chemistry and Biocatalysis Regulatory Filings	2026-01-16	English